Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03662074
Title Second Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Wake Forest University Health Sciences
Indications

lung small cell carcinoma

Therapies

Gemcitabine + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field